| Dr John Chao-chung Wu, MD | |
|
200 Hospital Cir, Westminster, CA 92683-3910 | |
| (818) 340-9988 | |
| (818) 587-2493 |
| Full Name | Dr John Chao-chung Wu |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 200 Hospital Cir, Westminster, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295804201 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2614 (Minnesota) | Secondary |
| 207P00000X | Emergency Medicine | 318967 (New York) | Secondary |
| 207P00000X | Emergency Medicine | A93845 (California) | Primary |
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
Novartis announced today that the Committee for Medicinal Products for Human Use has recommended the approval of Cosentyx (secukinumab) in Europe to treat ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients.
Bioheart, Inc., announced today plans for establishing five Centers of Excellence in Latin America to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease beginning next month, April 2010. Bioheart entered into its first agreement with a leading treatment facilitator, Regenerative Medicine Institute of Tijuana, Mexico. Therapies for CHF and PAD patients will be made available at the Hospital Angeles Tijuana, a fully equipped state-of–the-art private specialties hospital. This will be the first of five Centers of Excellence with four additional Centers to be announced in the coming months.
Scientists have found that genetic variations for an enzyme involved in cell energy metabolism may increase the risk of prostate cancer. This variation in genes may impair the enzyme phosphodiesterase 11A (PDE11A), which helps regulate cells' responses to hormones and other signals, according to the U.S. National Institute of Child Health and Human Development researchers and colleagues.
Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter.
› Verified 3 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366539421 PECOS PAC ID: 0547173866 Enrollment ID: O20230421002260 |
News Archive
Novartis announced today that the Committee for Medicinal Products for Human Use has recommended the approval of Cosentyx (secukinumab) in Europe to treat ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients.
Bioheart, Inc., announced today plans for establishing five Centers of Excellence in Latin America to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease beginning next month, April 2010. Bioheart entered into its first agreement with a leading treatment facilitator, Regenerative Medicine Institute of Tijuana, Mexico. Therapies for CHF and PAD patients will be made available at the Hospital Angeles Tijuana, a fully equipped state-of–the-art private specialties hospital. This will be the first of five Centers of Excellence with four additional Centers to be announced in the coming months.
Scientists have found that genetic variations for an enzyme involved in cell energy metabolism may increase the risk of prostate cancer. This variation in genes may impair the enzyme phosphodiesterase 11A (PDE11A), which helps regulate cells' responses to hormones and other signals, according to the U.S. National Institute of Child Health and Human Development researchers and colleagues.
Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Chao-chung Wu, MD Po Box 4419, Woodland Hills, CA 91365-4419 Ph: (818) 340-9988 | Dr John Chao-chung Wu, MD 200 Hospital Cir, Westminster, CA 92683-3910 Ph: (818) 340-9988 |
News Archive
Novartis announced today that the Committee for Medicinal Products for Human Use has recommended the approval of Cosentyx (secukinumab) in Europe to treat ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients.
Bioheart, Inc., announced today plans for establishing five Centers of Excellence in Latin America to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease beginning next month, April 2010. Bioheart entered into its first agreement with a leading treatment facilitator, Regenerative Medicine Institute of Tijuana, Mexico. Therapies for CHF and PAD patients will be made available at the Hospital Angeles Tijuana, a fully equipped state-of–the-art private specialties hospital. This will be the first of five Centers of Excellence with four additional Centers to be announced in the coming months.
Scientists have found that genetic variations for an enzyme involved in cell energy metabolism may increase the risk of prostate cancer. This variation in genes may impair the enzyme phosphodiesterase 11A (PDE11A), which helps regulate cells' responses to hormones and other signals, according to the U.S. National Institute of Child Health and Human Development researchers and colleagues.
Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter.
› Verified 3 days ago
Dr. Jamie Barton Lewis, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 15464 Goldenwest St, Westminster, CA 92683 Phone: 714-891-9008 Fax: 714-893-2239 | |
Dr. Eduardo D. Lam, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 Hospital Cir, Westminster, CA 92683 Phone: 818-340-9988 Fax: 818-587-2493 | |
Alan Conway Sonne, M.D Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 15464 Goldenwest St, Westminster, CA 92683 Phone: 714-891-9008 | |
Perry Le Dinh, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 14281 Beach Blvd, Westminster, CA 92683 Phone: 718-893-8800 | |
Dr. Travis Hamilton Parker, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 Hospital Cir, Westminster, CA 92683 Phone: 818-340-9988 Fax: 818-587-2493 | |
Andrew S Givner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Hospital Cir, Westminster, CA 92683 Phone: 714-893-4541 Fax: 818-587-2493 |